ROR1 and B-cell chronic lymphocytic leukemia: To investigate the potential of 22.0405.aF to control B-CLL in vivo, CB-17 severe immunodeficient (SCID) mice were injected intravenously with MEC-1-ROR1 cells, a human CLL cell line overexpressing human ROR1 (~28–32K ROR1/cell).